Share the post "Caplin Point Laboratories : Q4 2024 Financial Quarterly Report : YoY Sales Up 16.43 %, QoQ Up 4.07 %"
Highlights
- Sales over the Year and quarter: The company experienced a substantial growth of 16.43 % in the past year, substantial increase in net sales/revenue by 4.07 %.
- Income over the Year and quarter: There has been either a marginal increase or a decline in other income over the past year which is 51.67 %. Marginal increase in other income during this quarter, up by 0.46%.
- Profit over the Year and quarter: Significant improvement in profitability for Caplin Point Laboratories Ltd.. Notable increase of 19.75 % in net profit Year to Year, Caplin Point Laboratories Ltd.’s profitability increased by 1.17 % in this quarter.
- EPS over the Year and quarter: EPS increased by 19.03 % Year to Year. EPS increased by 3.69 % in previous quarter. Positive impact on shareholders.
| Metrics | Previous Year | Previous Quarter | Current Quarter | Quarter to Quarter Difference | Year to Year Difference |
|---|---|---|---|---|---|
| Sales | Rs. 389.28 Cr | Rs. 435.5 Cr | Rs. 453.22 Cr | + 4.07 % | + 16.43 % |
| Expenses | Rs. 265.35 Cr | Rs. 293.23 Cr | Rs. 307.99 Cr | + 5.03 % | + 16.07 % |
| Operating Profit | Rs. 123.93 Cr | Rs. 142.27 Cr | Rs. 145.23 Cr | + 2.08 % | + 17.19 % |
| OPM % | 31.84 % | 32.67 % | 32.04 % | -0.63 % | + 0.2 % |
| Other Income | Rs. 11.4 Cr | Rs. 17.21 Cr | Rs. 17.29 Cr | + 0.46 % | + 51.67 % |
| Interest | Rs. 0.23 Cr | Rs. 0.17 Cr | Rs. 0.15 Cr | -11.76 % | -34.78 % |
| Depreciation | Rs. 11.13 Cr | Rs. 13.9 Cr | Rs. 16.4 Cr | + 17.99 % | + 47.35 % |
| Profit before tax | Rs. 123.97 Cr | Rs. 145.41 Cr | Rs. 145.97 Cr | + 0.39 % | + 17.75 % |
| Tax % | 18.39 % | 17.6 % | 16.98 % | -0.62 % | -1.41 % |
| Net Profit | Rs. 101.24 Cr | Rs. 119.83 Cr | Rs. 121.23 Cr | + 1.17 % | + 19.75 % |
| EPS in Rs | Rs. 13.45 | Rs. 15.44 | Rs. 16.01 | + 3.69 % | + 19.03 % |
Today, we’re looking at Caplin Point Laboratories Ltd.’s financial performance for the Q4(Mar 2024).Starting with the top line, the company reported a robust year-over-year sales growth of 16.43 %. However, it did see a marginal increase of 4.07 % from the previous quarter. Expenses ticked up slightly by 5.03 % quarter-on-quarter, aligning with the annual rise of 16.07 %. Operating profit, while up 17.19 % compared to last year, faced a quarter-on-quarter increase of 2.08 %, signaling a short-term expansion in margins.
The Operating Profit Margin (OPM) % echoes this narrative, showing resilience on an annual basis with an increase of 0.2 %, but a shrinkage of -0.63 % sequentially. Other income rose by 0.46 % compared to the last quarter, despite an annual growth of 51.67 %. Interest expenses dropped significantly by -11.76 % from the previous quarter, yet the year-over-year decrease remains at a moderate -34.78 %. Depreciation costs climbed by 17.99 % quarter-on-quarter, whereas on an annual scale, they saw an increase of 47.35 %. Profit before tax grew annually by 17.75 % but saw an increase from the preceding quarter by 0.39 %.
Tax expenses as a percentage of profits decreased slightly by -1.41 % compared to last year, with a more notable quarter-on-quarter decrease of -0.62 %. Net profit rose by 19.75 % year-on-year but experienced a 1.17 % expansion from the last quarter. And finally, Earnings Per Share (EPS) displayed an annual uptick of 19.03 % but a quarterly rise of 3.69 %. In summary, Caplin Point Laboratories Ltd.’s annual performance indicates steady growth, although the quarter-on-quarter figures suggest some areas may require strategic attention.
| Metrics | Previous Year | Previous Quarter | Current Quarter | Quarter to Quarter Difference | Year to Year Difference |
|---|---|---|---|---|---|
| Sales | Rs. 389.28 Cr | Rs. 435.5 Cr | Rs. 453.22 Cr | + 4.07 % | + 16.43 % |
| Expenses | Rs. 265.35 Cr | Rs. 293.23 Cr | Rs. 307.99 Cr | + 5.03 % | + 16.07 % |
| Operating Profit | Rs. 123.93 Cr | Rs. 142.27 Cr | Rs. 145.23 Cr | + 2.08 % | + 17.19 % |
| Net Profit | Rs. 101.24 Cr | Rs. 119.83 Cr | Rs. 121.23 Cr | + 1.17 % | + 19.75 % |
| EPS in Rs | Rs. 13.45 | Rs. 15.44 | Rs. 16.01 | + 3.69 % | + 19.03 % |
In reviewing Caplin Point Laboratories Ltd.’s 2024(Q4) financial snapshot, key trends emerge, shedding light on the company’s performance.Sales saw a robust 16.43 % year-on-year growth, however, there was a minor increase of 4.07 % from the previous quarter. Expenses rose by 16.07 % compared to the previous year, with a 5.03 % increase quarter-on-quarter. Operating Profit surged by 17.19 % annually, and saw a 2.08 % increase from the last quarter.
Net Profit showed yearly increase of 19.75 %, and experienced a 1.17 % increase from the previous quarter. Earnings Per Share (EPS) rose by 19.03 % annually, however rose by 3.69 % compared to the last quarter. In essence, while Caplin Point Laboratories Ltd. exhibits strong annual growth indicators, short-term improvements suggest the potential for recovery and the importance of strategic adjustments to counter market challenges effectively. That’s all for now in the financial sector.
